Genesis Embryology Private Limited
About Genesis Embryology Private Limited
Data last updated:
Genesis Embryology Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the hospital services segment of the healthcare sector. It was incorporated on 16 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U85110GJ2014PTC080143. Its GSTIN is 24AAFCG7723G1ZP (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Bhargav Vyas and Shobhan Ratilal Vyas.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Vadodara, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.82 Lakh, a growth of 19% compared to the previous year. For the same year it recorded a net loss of ₹11.18 Lakh (net margin -80.9%) and EBITDA of ₹82,007 (EBITDA margin 5.9%). Revenue has grown at a compounded annual rate (CAGR) of 318% over five years.
As per MCA filings, the company has open charges of ₹20.25 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Genesis Embryology Private Limited's registered office is in Vadodara, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address78/1 – 5 C, GIDC Makarpura, Vadodara, Gujarat, India – 390010
- IndustryHealthcare, Hospital Services
To see the full contact details of Genesis Embryology Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Genesis Embryology is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Genesis Embryology Private Limited, buy the company report.
Financials of Genesis Embryology Private Limited
FY 2025 filings availableGenesis Embryology Private Limited reported revenue of ₹13.82 Lakh (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 318% over five years, including 19% growth in the latest year. EBITDA fell 51% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹82,007 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹11.18 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.9% | ||||
| Net Profit Margin | -80.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Genesis Embryology Private Limited, buy the company report.
Board of directors of Genesis Embryology Private Limited
Genesis Embryology has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhargav Vyas Also directs: Monash Biotech Private Limited | Director | 25 Aug 2022 | 4 Years 2 Months | Current |
| Shobhan Ratilal Vyas Also directs: Monash Biotech Private Limited, Monash Biomed Private Limited | Director | 27 Jan 2015 | 11 Years 9 Months | Current |
| Paul John Verma Also directs: Monash Biotech Private Limited | Director | 16 Jul 2014 | 12 Years 3 Months | Current |
Peer comparison
Genesis Embryology Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (IVF and Maternity), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| New Rajasthan Fertility Hospital Research Centre Private Limited | ₹14.73 Lakh (FY 2018) | -1.0% | Jaisalmer, Rajasthan, India | |||
| Genesis Embryology Private Limitedthis company | ₹13.82 Lakh (FY 2025) | -₹11.18 Lakh | -80.9% | 19.0% | Vadodara, Gujarat, India | |
| Ilove 9 Months Fitness Solutions Private Limited | ₹12.98 Lakh (FY 2022) | -2.0% | Via Puvathur, Kerala, India | |||
| Santasa Women Health Private Limited | ₹11.13 Lakh (FY 2025) | 188.0% | Mysore, Karnataka, India |
To see the full peer comparison of Genesis Embryology Private Limited, buy the company report.
Auditor
Genesis Embryology Private Limited is audited by GAURANG I PARIKH & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GAURANG I PARIKH & CO. | FY 2017 | 103103W |
Shareholding
The shareholding of Genesis Embryology Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Genesis Embryology Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jan 2015 | 10547266 | Bank of Baroda | ₹20.25 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Genesis Embryology Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Genesis Embryology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Genesis Embryology has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAFCG7723G1ZP | Gujarat | Active | 04 Dec 2021 |
To see the full GST registrations and return filing status of Genesis Embryology Private Limited, buy the company report.
Recent activity
Genesis Embryology Private Limited has 4 board changes on record since 2014: 3 appointments and 1 cessation. The latest: Bhargav Vyas was appointed as Director on 25 Aug 2022.
Frequently asked questions
Genesis Embryology is an active private limited company based in Vadodara, Gujarat, India. The company works in hospital services, within the healthcare industry. It was incorporated on 16 July 2014 (12+ years old) and is registered under CIN U85110GJ2014PTC080143.
Genesis Embryology has 3 current directors:
- Bhargav Vyas - Director
- Shobhan Ratilal Vyas - Director
- Paul John Verma - Director
The latest financial statements of Genesis Embryology on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Genesis Embryology is 24AAFCG7723G1ZP, registered in Gujarat.
The CIN (Corporate Identification Number) of Genesis Embryology is U85110GJ2014PTC080143. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genesis Embryology was incorporated on 16 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Genesis Embryology by revenue are New Rajasthan Fertility Hospital Research Centre Private Limited, Ilove 9 Months Fitness Solutions Private Limited, Santasa Women Health Private Limited, all in the Healthcare industry (IVF and Maternity), with the same principal business activity (other hospital and medical care activities).
Bhargav Vyas was appointed as Director on 25 Aug 2022. Rajendra Singh Pundir ceased to be Director on 30 Aug 2021. Shobhan Ratilal Vyas was appointed as Director on 27 Jan 2015. Genesis Embryology has 4 board changes on record in total.
The registered office of Genesis Embryology is at 781 – 5 C, GIDC Makarpura, Vadodara, Gujarat, India – 390010.
Genesis Embryology operates in the healthcare industry, in the hospital services segment.
Genesis Embryology has open charges of ₹20.25 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
